Therefore, in addition to prominent steatosis and extensive necroinflammation, the MCD-fed mice also show significant weight loss, no insulin resistance, and low serum insulin, fasting glucose, leptin, and triglyceride levels,45 a metabolic profile opposite to what has been observed in obese patients with MASLD. This evidence concerns the gene INS and steatosis.